Pharma Equity Group A/S (CPH:PEG)
Denmark
· Delayed Price · Currency is DKK 0.0948
+0.0024 (2.60%)
Mar 6, 2026, 3:24 PM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 116.37 million as of March 6, 2026. Its market cap has decreased by -35.51% in one year.
Market Cap
116.37M
Enterprise Value
134.12M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 116.37M, a decrease of -84.83%. That is a compound annual growth rate of -47.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 116.37M | 1.50% |
| Dec 30, 2025 | 114.65M | -50.84% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,104.89B |
| Genmab | 109.14B |
| Coloplast | 103.96B |
| ALK-Abelló | 49.85B |
| BioPorto | 465.89M |
| ViroGates | 111.38M |
| Scandinavian Medical Solutions | 89.54M |
| Stenocare | 58.10M |